So far, large-scale whole-exome sequencing of ESCC have unveiled several high frequency of mutations (e.g., TP53 and CDKN2A) and mutational processes (e.g., cell cycle and PI3K-AKT pathways) [6, 7]. Here, AKT1 is linked to esophageal squamous cell carcinoma.